Nitric oxide-cGMP signaling in hypertension: current and future options for pharmacotherapy E Ataei Ataabadi, K Golshiri, A Jüttner, G Krenning, AHJ Danser, ... Hypertension 76 (4), 1055-1068, 2020 | 49 | 2020 |
The importance of the nitric oxide‐cGMP pathway in age‐related cardiovascular disease: Focus on phosphodiesterase‐1 and soluble guanylate cyclase K Golshiri, E Ataei Ataabadi, EC Portilla Fernandez, AH Jan Danser, ... Basic & clinical pharmacology & toxicology 127 (2), 67-80, 2020 | 43 | 2020 |
Clinical effects of Rhus coriaria fruits on dyslipidemia in adolescents: a triple-blinded randomized placebo-controlled trial AM Sabzghabaee, R Kelishadi, K Golshiri, A Ghannadi, S Badri Medical archives 68 (5), 308, 2014 | 42 | 2014 |
Vascular ageing features caused by selective DNA damage in smooth muscle cell E Ataei Ataabadi, K Golshiri, J van der Linden, M de Boer, DJ Duncker, ... Oxidative Medicine and Cellular Longevity 2021 (1), 2308317, 2021 | 18 | 2021 |
Enhancement in dissolution rate of piroxicam by two micronization techniques J Varshosaz, A Khajavinia, M Ghasemlu, E Ataei, K Golshiri, I Khayam Dissolution Technol 20 (3), 15-23, 2013 | 17 | 2013 |
Chronic sildenafil treatment improves vasomotor function in a mouse model of accelerated aging K Golshiri, E Ataei Ataabadi, R Brandt, I van der Pluijm, R de Vries, ... International Journal of Molecular Sciences 21 (13), 4667, 2020 | 13 | 2020 |
Selective phosphodiesterase 1 inhibition ameliorates vascular function, reduces inflammatory response, and lowers blood pressure in aging animals K Golshiri, EA Ataabadi, E Rubio-Beltran, S Dutheil, W Yao, GL Snyder, ... Journal of Pharmacology and Experimental Therapeutics 378 (2), 173-183, 2021 | 11 | 2021 |
Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accelerated ageing mouse model E Ataei Ataabadi, K Golshiri, AA Jüttner, R de Vries, ... Aging Cell 21 (9), e13683, 2022 | 7 | 2022 |
The effects of acute and chronic selective phosphodiesterase 1 inhibition on smooth muscle cell-associated aging features K Golshiri, EA Ataabadi, AA Jüttner, GL Snyder, RE Davis, A Lin, L Zhang, ... Frontiers in Pharmacology 12, 818355, 2022 | 7 | 2022 |
Adiponectin secretion by perivascular adipose tissue supports impaired vasodilation in a mouse model of accelerated vascular smooth muscle cell and adipose tissue aging AA Jüttner, EA Ataabadi, K Golshiri, R de Vries, IM Garrelds, AHJ Danser, ... Vascular Pharmacology 154, 107281, 2024 | | 2024 |
Clinical Impact And Mechanisms Of Non-Atherosclerotic Vascular Aging: The New Kid to be Blocked SM Jouabadi, EA Ataabadi, K Golshiri, D Bos, BHC Stricker, AHJ Danser, ... Canadian Journal of Cardiology, 2023 | | 2023 |
The sGC activator BAY 54-6544 improves vascular function and survival in an accelerated aging model E Ataei, K Golshiri, I van der Pluijm, J Danser, P Sandner, A Roks JOURNAL OF TRANSLATIONAL MEDICINE 21 (SUPPL 1), 2023 | | 2023 |
Soluble Guanylate Cyclase Activator Treatment Improves Vasomotor Function in an Accelerated-Ageing Mouse Model E Ataei Ataabadi, K Golshiri, R de Vries, RMC Brandt, I Van Der Pluijm, ... Circulation 144 (Suppl_1), A9317-A9317, 2021 | | 2021 |
The Effects of Acute and Chronic Selective Phosphodiesterase 1 Inhibition in Associated Smooth Muscle Cell-Specific Aging Features K Golshiri, E Ataei Ataabadi, R de Vries, L Zhang, S Chalgeri, A Lin, ... Circulation 144 (Suppl_1), A10955-A10955, 2021 | | 2021 |
THE EFFECTS OF ITI-214 (A NEW PHOSPHODIESTERASE 1 INHIBITOR) ON VASCULAR AGEING FEATURES ASSOCIATED TO DNA REPAIR RESPONSE IN MICE K Golshiri, E Ataei, R Van Veghel, GL Snyder, L Zhang, P Li, RE Davis, ... Journal of Hypertension 39, e67, 2021 | | 2021 |
DNA REPAIR DEFECT IN SMOOTH MUSCLE CELL REPRODUCES FEATURES OF AGE-RELATED VASCULAR DISEASE IN MICE EA Ataabadi, K Golshiri, R De Vries, GL Snyder, L Zhang, P Li, RE Davis, ... Journal of Hypertension 39, e67, 2021 | | 2021 |
Selective PDE1 inhibition ameliorates vascular function, reduces inflammatory response, and lowers blood pressure in ageing animals K Golshiri, E Ataei Ataabadi, E Rubio‐Beltran, S Dutheil, W Yao, ... Journal of Pharmacology and Experimental Therapeutics 378, 173-183, 2021 | | 2021 |
Central Angiotensin II Mediates Neurogenic Hypertension Through Hif1-Alpha/NMDAR Axis In The Paraventricular Nucleus Of The Hypothalamus (PVN). N Sharma, AS Haibara, K Katsurada, SS Nandi, KP Patel HYPERTENSION 76, 2020 | | 2020 |